share_log

Gritstone Bio Q1 2024 GAAP EPS $(0.34) Misses $(0.31) Estimate, Sales $1.742M Beat $1.104M Estimate

Benzinga ·  May 9 16:51

Gritstone Bio (NASDAQ:GRTS) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 13.33 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $1.742 million which beat the analyst consensus estimate of $1.104 million by 57.77 percent. This is a 28.69 percent decrease over sales of $2.443 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment